OTC Markets EXMKT - Delayed Quote USD
Immunotech Laboratories, Inc. (IMMB)
0.0001
0.0000
(0.00%)
As of April 29 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
Operating Expense
958.9350
Operating Income
-958.9350
Net Non Operating Interest Income Expense
-18.6350
Pretax Income
-977.5700
Net Income Common Stockholders
-977.5700
Diluted NI Available to Com Stockholders
-977.5700
Basic EPS
-1.78
Diluted EPS
-1.78
Total Operating Income as Reported
-958.9350
Total Expenses
958.9350
Net Income from Continuing & Discontinued Operation
-977.5700
Normalized Income
-977.5700
Interest Expense
18.6350
Net Interest Income
-18.6350
EBIT
-958.9350
EBITDA
-944.5860
Reconciled Depreciation
14.3490
Net Income from Continuing Operation Net Minority Interest
-977.5700
Normalized EBITDA
-944.5860
4/9/57299 - 12/27/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TSVT 2seventy bio, Inc.
5.0000
+0.20%
PTCT PTC Therapeutics, Inc.
49.36
-0.32%
PGEN Precigen, Inc.
1.5000
-2.60%
MESO Mesoblast Limited
11.43
-4.07%
BEAM Beam Therapeutics Inc.
19.25
-2.33%
ABCL AbCellera Biologics Inc.
2.4909
-2.32%
DNA Ginkgo Bioworks Holdings, Inc.
7.21
-2.31%
RXRX Recursion Pharmaceuticals, Inc.
5.41
-5.42%